Bellevue Group AG

Q3 2020 13F-HR Holdings

Location
Kuesnacht, V8
Holdings as of
9/30/2020
Date filed
11/16/2020
Form type
13F-HR
Num holdings
217
Total value ($000)
$7,237,378
Net value change ($000)
+171,470 (2.4%)
New positions
20
Sold out positions
11
Turnover %
2.3%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/13/2020 Next filing: 2/16/2021 SEC filing

Snapshot: Change Analysis

Compared to Q2 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
RLAY 55,367 NEW
Sage Therapeutics, Inc. 37,683 64.0%
MyoKardia, Inc. 37,088 31.8%
ARGX 36,888 17.2%
EXAS 31,043 NEW
GBIO 27,871 92.2%
ABT 22,783 19.4%
MRNA 21,664 10.1%
FATE 21,339 31.7%
CRSP 20,570 35.0%
Top Reduces (Value $000, Stocks/ETFs)
NBIX -74,647 -19.1%
IONS -72,825 -15.0%
AGIO -69,895 -32.5%
ESPR -68,944 -25.3%
INCY -48,033 -14.0%
HALO -36,717 -20.3%
Myovant Sciences Ltd. -24,279 -25.3%
VRTX -23,860 -8.4%
NKTR -21,610 -26.4%
ILMN -17,475 -49.1%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type